BlattnerWA,KalynaramanVS,Robert-GuroffM,ListerTA,GaltonDA,SarinPS, 1982.The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/ lymphoma,Int J Cancer 30 257 -64
TreviñoA,VicarioJL,LopezM,ParraP,BenitoR,Ortiz de Lejarazu R,J Neurol, 2013.Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1, 260 2551 -5
ProiettiFA,Carneiro-ProiettiAB,Catalan-SoaresBC,MurphyEL, 2005.Global epidemiology of HTLV-I infection and associated diseases,Oncogene 24 6058 -68
CalattiniS,ChevalierSA,DuprezR,BassotS,FromentA,MahieuxR, 2005.Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa,Retrovirology 2 30 -
TakatsukiK,MatsuokaM, 1996.Yamaguchi K. Adult T-cell leukemia in Japan,J Acquir Immune Defic Syndr Hum Retrovirol 13 S15 -S19
AlvaIE,OrellanaER,BlasMM,Bernabe-OrtizA,CotrinaA,ChiappeM, 2012.HTLV-1 and -2 infections among 10 indigenous groups in the Peruvian Amazon,Am J Trop Med Hyg 87 954 -6
DelaporteE,PeetersM,DurandJP,DupontA,SchrijversD,BedjabagaL, 1989.Seroepidemiological survey of HTLV-1 infection among randomized populations of western central African countries,J Acquir Immune Defic Syndr 2 410 -3
AbbaszadeganMR,GholaminM,TabatabaeeA,FaridR,HoushmandM,AbbaszadeganM, 2003.Prevalence of human T-lymphotropic virus type-1 among blood donors from Mashhad, Iran,J Clin Microbiol 41 2593 -5
MannsA,WilksRJ,MurphyEL,HaynesG,FigueroaJP,BarnettM, 1992.A progressive study of transmission by transfusion of HTLV-1 and risk factors associated with seroconversion,Int J Cancer 51 886 -91
CouroucéAM,PillonelJ,LemaireJM, 1998.HTLV testing in blood transfusion,Vox Sang 74 165 -9
AnderssonS,GessainA,Taylor G, 2001.Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus (HTLV) types I and II,Virus Res 78 101 -6
DowBC,MunroH,FergusonK,BuchananI,JarvisL,JordanT, 2001.HTLV antibody screening using mini-pools,Transfus Med 11 419 -22
Ul-HassanZ,Al-BahraniAT,PanhotraBR, 2004.Prevalence of human T-lymphotropic virus type-I and type-II antibody among blood donors in Eastern Saudi Arabia,Saudi Med J 25 1419 -22
MaY,ZhengS,WangN,DuanY,SunX,JinJ, 2013.Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China,PLoS One 8 e66795 -
ChangYB,KaidarovaZ,HindesD,BravoM,KielyN,KamelH, 2014.Seroprevalence and demographic determinants of human T-lymphotropic virus type-1 and 2 infections among first-time blood donors-United States,,J Infect Dis 209 523 -31
TynellE,AnderssonS,LithanderE,ArnebornM,BlombergJ,HanssonHB, 1998.Screening for human T-cell leukaemia/ lymphoma virus among blood donors in Sweden: cost effectiveness analysis,BMJ 316 1417 -22
DavisonKL,DowB,BarbaraJA,HewittPE,EglinR., 2009.The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV,Transfus Med 19 24 -34
GastaldelloR,HallWW,GallegoS., 2004.Seroepidemiology of HTLV-I/II in Argentina: an overview,J Acquir Immune Defic Syndr 35 301 -8
RouetF,RabierR,FoucherC,ChancerelB,AgisF,StrobelM., 1999.Geographical clustering of human T-cell lymphotropic virus type-I in Guadeloupe, an endemic Caribbean area,Int J Cancer 81 330 -4
PintoMT,RodriguesES,MaltaTM,AzevedoR,TakayanaguiOM,ValenteVB, 2012.HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up,Rev Inst Med Trop Sao Paulo 54 123 -9
RouetF,FoucherC,RabierM,GawronskiI,TaverneD,ChancerelB, 1999.Human T-lymphotropic virus type-I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics,Transfusion 39 639 -44
GoutO,BaulacM,GessainA,SemahF,SaalF,PérièsJ, 1990.Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation,N Engl J Med 322 383 -8
SatakeM,YamaguchiK,TadokoroK., 2012.Current prevalence of HTLV-1 in Japan as determined by screening of blood donors,J Med Virol 84 327 -5